Alpha Cognition (ACOG) Capital Expenditures (2025)

Alpha Cognition (ACOG) posted quarterly Capital Expenditures of $147523.0 for Q4 2025, up 98.33% quarter-over-quarter from $74381.0 in Q3 2025.

Alpha Cognition (ACOG) Capital Expenditures (2025) Analysis & Trends

Alpha Cognition's Capital Expenditures history runs 1 years deep, the most recent figure standing at $147523.0 for Q4 2025.

In Q4 2025, Capital Expenditures changed N/A year-over-year to $147523.0; the TTM figure through Dec 2025 stood at $293489.0 (changed N/A YoY), while the FY2025 annual figure was $293489.0, up 999.17% from the prior year.
Capital Expenditures for Q4 2025 stood at $147523.0, up from $74381.0 in the prior quarter.
The five-year high for Capital Expenditures was $147523.0 in Q4 2025, with the low at $8315.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Vertex Pharmaceuticals	138.89 Bn	131.04 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	86.05 Bn	78.06 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	65.56 Bn	60.38 Bn	1.37 Bn	-
4	Moderna	55.46 Bn	50.32 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn	25.02 Mn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn	34.68 Mn
7	BioNTech SE	27.70 Bn	9.30 Bn	668.28 Mn	-73.57 Mn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn	6.26 Mn
9	Royalty Pharma	27.38 Bn	26.54 Bn	-	251.02 Mn
10	Alpha Cognition	207.07 Mn	165.63 Mn	5.70 Mn	-

Download Data